The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDRLiang Zhou, Steven Grant, Yun Leng et al.|Blood|2016Cited by 58
Non-canonical role for the ataxia-telangiectasia-Rad3 pathway in STAT3 activation in human multiple myeloma cellsLin Li, Steven Grant, Jewel Nkwocha et al.|Cellular Oncology|2023Cited by 9